AA
XFOR icon

ALPS Advisors’s X4 Pharmaceuticals XFOR Stock Holding History

ALPS Advisors’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Buy
+95,726
New +$393K ﹤0.01% 1022

Other funds holding XFOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

ALPS Advisors's XFOR Position: Q2 2026 in Review

ALPS Advisors opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 95,726 shares worth $447K. The stake represents ﹤0.01% of the portfolio and ranks #1022 among its holdings.

19 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • ALPS Advisors held 95,726 shares of X4 Pharmaceuticals worth $447K as of Q2 2026.
  • X4 Pharmaceuticals was a new ALPS Advisors position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1022 holding.
  • 19 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.